About 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one (PubChem CID 15599410) has the molecular formula C13H15N3O2
and a molecular weight of 245.28 g/mol. Its IUPAC name is 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one.
Analyze 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one?
The IUPAC name of 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one (CID 15599410) is 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one.
What is the SMILES notation for 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one?
The canonical SMILES for 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one is CC1CC(=O)NN=C1c1ccc2c(c1)NCCO2.
What is the InChIKey of 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one?
The InChIKey is FKNGGIVXAZWJLM-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H15N3O2/c1-8-6-12(17)15-16-13(8)9-2-3-11-10(7-9)14-4-5-18-11/h2-3,7-8,14H,4-6H2,1H3,(H,15,17).
What are the key properties of 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one?
3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one has a molecular weight of 245.28 g/mol, XLogP of 1.35, 1 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one is sourced from PubChem (CID 15599410), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).